These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31876226)

  • 1. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 2. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway.
    Gao Y; Fei X; Kong L; Tan X
    Anticancer Drugs; 2020 Sep; 31(8):828-835. PubMed ID: 32796404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
    He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
    Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.
    Zhou B; Guo W; Sun C; Zhang B; Zheng F
    Cell Death Dis; 2018 Jun; 9(6):706. PubMed ID: 29899418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
    Li N; Gou JH; Xiong J; You JJ; Li ZY
    BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
    Chang J; Hu X; Nan J; Zhang X; Jin X
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
    Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
    Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
    Zhang X; Tan P; Zhuang Y; Du L
    Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.
    Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L
    Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
    Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
    J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
    Wan X; Guo D; Zhu Q; Qu R
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G309-G322. PubMed ID: 32463333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.